RILPL2 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
macrophage	30 studies	30% ± 12%	Explore
classical monocyte	27 studies	46% ± 14%	Explore
conventional dendritic cell	25 studies	38% ± 18%	Explore
non-classical monocyte	25 studies	43% ± 15%	Explore
monocyte	22 studies	35% ± 14%	Explore
regulatory T cell	20 studies	22% ± 5%	Explore
B cell	19 studies	24% ± 6%	Explore
memory B cell	16 studies	26% ± 8%	Explore
dendritic cell	15 studies	39% ± 18%	Explore
endothelial cell	13 studies	29% ± 10%	Explore
CD4-positive, alpha-beta T cell	12 studies	25% ± 6%	Explore
myeloid cell	12 studies	35% ± 15%	Explore
T cell	10 studies	21% ± 4%	Explore
CD8-positive, alpha-beta T cell	10 studies	20% ± 3%	Explore
plasmacytoid dendritic cell	10 studies	31% ± 10%	Explore
endothelial cell of artery	9 studies	23% ± 4%	Explore
mast cell	8 studies	28% ± 9%	Explore
neutrophil	8 studies	35% ± 6%	Explore
capillary endothelial cell	8 studies	20% ± 3%	Explore
ciliated cell	8 studies	26% ± 9%	Explore
endothelial cell of vascular tree	8 studies	24% ± 6%	Explore
leukocyte	7 studies	30% ± 11%	Explore
T follicular helper cell	7 studies	26% ± 7%	Explore
hematopoietic precursor cell	6 studies	42% ± 17%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	23% ± 6%	Explore
platelet	6 studies	20% ± 2%	Explore
naive B cell	6 studies	20% ± 3%	Explore
hematopoietic stem cell	6 studies	30% ± 7%	Explore
CD8-positive, alpha-beta memory T cell	6 studies	20% ± 3%	Explore
mononuclear phagocyte	5 studies	41% ± 21%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	20% ± 4%	Explore
intermediate monocyte	5 studies	54% ± 22%	Explore
natural killer cell	4 studies	19% ± 1%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	4 studies	21% ± 6%	Explore
glomerular endothelial cell	4 studies	40% ± 9%	Explore
megakaryocyte	4 studies	34% ± 7%	Explore
fibroblast	4 studies	19% ± 3%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	25% ± 8%	Explore
effector memory CD8-positive, alpha-beta T cell	4 studies	22% ± 5%	Explore
granulocyte	4 studies	25% ± 8%	Explore
alveolar macrophage	4 studies	19% ± 5%	Explore
monocyte-derived dendritic cell	3 studies	54% ± 19%	Explore
exhausted T cell	3 studies	26% ± 1%	Explore
common myeloid progenitor	3 studies	36% ± 13%	Explore
innate lymphoid cell	3 studies	30% ± 8%	Explore
effector CD4-positive, alpha-beta T cell	3 studies	23% ± 4%	Explore
gamma-delta T cell	3 studies	25% ± 8%	Explore
granulocyte monocyte progenitor cell	3 studies	35% ± 17%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	34% ± 17%	Explore
basal cell	3 studies	22% ± 7%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	15 studies	24% ± 8%	Explore
lung	6 studies	27% ± 9%	Explore
bone marrow	4 studies	20% ± 4%	Explore
lymph node	4 studies	20% ± 3%	Explore
kidney	3 studies	22% ± 4%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
thymus	100%	3235.90	653 / 653	100%	33.47	605 / 605
prostate	100%	2669.92	245 / 245	100%	18.81	500 / 502
uterus	100%	2583.78	170 / 170	99%	12.48	455 / 459
kidney	100%	1824.69	89 / 89	99%	18.50	892 / 901
lung	100%	3421.14	578 / 578	99%	12.72	1141 / 1155
breast	100%	2251.90	459 / 459	99%	14.97	1103 / 1118
bladder	100%	1430.10	21 / 21	96%	11.09	486 / 504
ovary	100%	1405.16	180 / 180	95%	7.57	409 / 430
esophagus	98%	1172.50	1410 / 1445	97%	8.34	178 / 183
intestine	99%	1218.37	952 / 966	95%	8.69	503 / 527
stomach	98%	975.11	351 / 359	96%	8.47	275 / 286
adrenal gland	98%	920.72	252 / 258	95%	10.08	219 / 230
skin	99%	1200.95	1791 / 1809	91%	8.57	428 / 472
brain	88%	685.31	2337 / 2642	100%	9.76	702 / 705
liver	73%	446.34	166 / 226	80%	5.20	326 / 406
pancreas	42%	223.63	137 / 328	99%	14.43	177 / 178
adipose	100%	2366.58	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	52.23	29 / 29
peripheral blood	100%	6235.85	929 / 929	0%	0	0 / 0
spleen	100%	3532.31	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	15.16	45 / 45
ureter	0%	0	0 / 0	100%	3.70	1 / 1
blood vessel	100%	3286.30	1334 / 1335	0%	0	0 / 0
heart	89%	684.82	765 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	51%	2.44	41 / 80
muscle	24%	120.77	189 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0060271	Biological process	cilium assembly
GO_0003382	Biological process	epithelial cell morphogenesis
GO_1903445	Biological process	protein transport from ciliary membrane to plasma membrane
GO_0005813	Cellular component	centrosome
GO_0005929	Cellular component	cilium
GO_0036064	Cellular component	ciliary basal body
GO_0005829	Cellular component	cytosol
GO_0016020	Cellular component	membrane
GO_0005737	Cellular component	cytoplasm
GO_0051959	Molecular function	dynein light intermediate chain binding
GO_0046983	Molecular function	protein dimerization activity
GO_0042802	Molecular function	identical protein binding
GO_0005515	Molecular function	protein binding
GO_0031267	Molecular function	small GTPase binding

IV. Literature review

[source]

Gene name	RILPL2
Protein name	RILP-like protein 2 (Rab-interacting lysosomal protein-like 2) (p40phox-binding protein)
Synonyms	RLP2
Description	FUNCTION: Involved in cell shape and neuronal morphogenesis, positively regulating the establishment and maintenance of dendritic spines (By similarity). Plays a role in cellular protein transport, including protein transport away from primary cilia (By similarity). May function via activation of RAC1 and PAK1 (By similarity). .
Accessions	Q969X0 ENST00000280571.10

RILPL2 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review